Interview: AstraZeneca sees Japan as a land of opportunity
This article was originally published in Scrip
Executive Summary
Compared with the doom and gloom pervading the industry in some other major markets, the generally brighter outlook in Japan and the rest of Asia is providing a welcome contrast for Mark Mallon.